News Quantified

MDGL – madrigal pharmaceuticals, inc. (US:NASDAQ)

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.

11/18

11:38 am

mdgl

Low

Wall Street Analysts Believe Madrigal (MDGL) Could Rally 26.44%: Here's is How to Trade [Yahoo! Finance]

1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More [Yahoo! Finance]

Here's Why Madrigal (MDGL) is a Great Momentum Stock to Buy [Yahoo! Finance]

Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}